mRNA technologies are not limited only to infectious diseases, but can also be applied in the treatment of cancer and gene diseases, said Grigory Stepanov, head of the genome editing laboratory of the Institute of Chemical Biology and Fundamental Medicine SB RAS, development director of the Biosan group of companies and “Biolabmix”.
“MRNA technology has a great future. They will revolutionize not only the prevention of infectious diseases but also the treatment of cancer. This will be a personalized treatment of oncological diseases; The drugs will be injected into cancer patients and will cause the body’s natural immune response to be directed against the tumors,” Stepanov explained.
Nobel Prize winners in Physiology or Medicine in 2023 become Credit to biochemists Katalin Karikó and Drew Weissman for developing the mRNA synthesis method that forms the basis of Pfizer and Moderna’s COVID-19 vaccines.
“Catalina Carico demonstrated the role of modified nucleotides in RNA in regulating the innate immune response. We also demonstrated that these modified nucleotides can be used to endow artificial RNA with properties that make it useful for humans,” he said.
Russian scientists before appreciated The Nobel Prize was awarded to mRNA vaccines against Covid-19.